BusinessTaconic Biosciences Expands Microbiome Product and Service PlatformBy Nasdaq OMXApr 26, 2017, 3:03 PM UTC
BusinessAssembly Biosciences Announces the Closing and Early Termination of Hart-Scott-Rodino Waiting Period for License of Microbiome Gastrointestinal Development Programs to AllerganBy Nasdaq OMXFeb 21, 2017, 12:05 PM UTC
BusinessAllergan Enters Into Licensing Agreement with Assembly Biosciences to Obtain Worldwide Rights to Microbiome Gastrointestinal Development ProgramsBy Nasdaq OMXJan 9, 2017, 1:02 PM UTC
BusinessAllergan Enters Into Licensing Agreement with Assembly Biosciences to Obtain Worldwide Rights to Microbiome Gastrointestinal Development ProgramsBy Nasdaq OMXJan 9, 2017, 1:02 PM UTC
BusinessAssembly Biosciences Announces Key Additions to Microbiome TeamBy Nasdaq OMXSep 28, 2016, 11:01 AM UTC
BusinessAssembly Biosciences Announces Key Additions to Microbiome TeamBy Nasdaq OMXSep 28, 2016, 11:01 AM UTC
BusinessSummit Announces Ridinilazole Preserves the Gut Microbiome of Patients With C. difficile Infection in Phase 2 TrialBy Nasdaq OMXMar 7, 2016, 12:00 PM UTC
BusinessAssembly Biosciences to Webcast Upcoming Investor ConferencesBy Nasdaq OMXFeb 19, 2016, 12:30 PM UTC
